Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (42)COVID-19 (33)

Type

TypeGuidance (3904)Indicators (274)News (248)NICE advice (493)Quality standards (254)Research recommendations (1918)

Status

StatusAwaiting development (338)Discontinued (410)In consultation (5)In development (387)Published (2465)Topic selection (287)

Last updated

Last updatedLast 3 months (74)Last 6 months (137)Last year (579)Last 3 years (1656)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (25)Cancer service guidelines (10)Clinical guidelines (381)COVID-19 NHSE/I specialty guides (2)COVID-19 rapid guidelines (27)Diagnostics guidance (93)Health technology evaluations (45)Highly specialised technologies guidance (48)Interventional procedures guidance (953)Medical technologies guidance (152)Medicines practice guidelines (5)NICE guidelines (562)Public health guidelines (88)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2047)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (321)

Showing 6871 to 6885 of 7704 results

Sort by

Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]
Discontinued [GID-TA10494]
Result type
Technology appraisal guidance
Status
Discontinued
Entinostat for treating hormone receptor-positive breast cancer after hormonal therapy [ID1260]
Discontinued [GID-TA10309]
Result type
Technology appraisal guidance
Status
Discontinued
Nivolumab with ipilimumab for neoadjuvant treatment of early non-small-cell lung cancer [ID3756]
Discontinued [GID-TA10631]
Result type
Technology appraisal guidance
Status
Discontinued
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Discontinued [GID-TA10375]
Result type
Technology appraisal guidance
Status
Discontinued
PEGPH20 with nab-paclitaxel and gemcitabine for treating metastatic pancreatic cancer ID1502
Discontinued [GID-TA10402]
Result type
Technology appraisal guidance
Status
Discontinued
Pelareorep for untreated pancreatic cancer [ID1074]
Discontinued [GID-TA10689]
Result type
Technology appraisal guidance
Status
Discontinued
Pelareorep for treating metastatic or recurrent squamous cell carcinoma of the head and neck after platinum-based chemotherapy ID940
Discontinued [GID-TA10397]
Result type
Technology appraisal guidance
Status
Discontinued
Pelareorep for treating metastatic malignant melanoma after previous therapy [ID941]
Discontinued [GID-TA10686]
Result type
Technology appraisal guidance
Status
Discontinued
Pelareorep for treating relapsed or refractory multiple myeloma [ID1028]
Discontinued [GID-TA10687]
Result type
Technology appraisal guidance
Status
Discontinued
Ublituximab with ibrutinib for previously treated chronic lymphocytic leukaemia [ID1476]
Discontinued [GID-TA10447]
Result type
Technology appraisal guidance
Status
Discontinued
Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma after autologous stem cell transplant [ID1103]
Discontinued [GID-TA10144]
Result type
Technology appraisal guidance
Status
Discontinued
Pelareorep for treating recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer [ID1099]
Discontinued [GID-TA10688]
Result type
Technology appraisal guidance
Status
Discontinued
Rigosertib for previously treated high-risk myelodysplastic syndrome [ID805]
Discontinued [GID-TA10709]
Result type
Technology appraisal guidance
Status
Discontinued
AT406 for neoadjuvant treatment of epithelial ovarian cancer [ID1428]
Discontinued [GID-TA10809]
Result type
Technology appraisal guidance
Status
Discontinued
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after alectinib or ceritinib [ID2702]
Discontinued [GID-TA10569]
Result type
Technology appraisal guidance
Status
Discontinued

Previous page
1
…
457
458
Current page 459
460
461
…
514
Page 459 of 514
Next page

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.